Yuan-Chia Chu Selected Research

Yuan-Chia Chu Research Topics

3	COVID-19 11/2023 - 01/2023
3	Hearing Loss (Hearing Impairment) 12/2022 - 04/2022
2	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 01/2022
2	Sepsis (Septicemia) 01/2022 - 01/2022
1	Infections 09/2023
1	Sudden Hearing Loss (Sudden Deafness) 03/2023
1	Epstein-Barr Virus Infections 03/2023
1	Neoplasms (Cancer) 01/2023
1	Pressure Ulcer (Bedsore) 11/2022
1	Proteinuria 02/2022
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2022
1	Myocardial Infarction 01/2021
1	Ischemic Stroke 01/2021
1	Thromboembolism 01/2021
1	Hemorrhage 01/2021
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021
1	Stroke (Strokes) 01/2021
1	Atrial Fibrillation 01/2021
1	Chronic Renal Insufficiency 01/2021
1	Hemorrhagic Stroke 01/2021

1	COVID-19 VaccinesIBA 09/2023
1	SteroidsIBA 03/2023
1	AntigensIBA 03/2023
1	DNA (Deoxyribonucleic Acid)IBA 03/2023
1	Viral DNAIBA 03/2023
1	Immunoglobulin A (IgA)IBA 03/2023
1	Acetylcysteine (Siran)FDA LinkGeneric 01/2023
1	ErbB Receptors (EGF Receptor)IBA 01/2023
1	Hemoglobins (Hemoglobin)IBA 02/2022
1	CreatinineIBA 01/2022
1	Warfarin (Coumadin)FDA LinkGeneric 01/2021
1	AnticoagulantsIBA 01/2021

3	Therapeutics 03/2023 - 01/2021
2	Renal Dialysis (Hemodialysis) 11/2023 - 09/2023
2	Hearing Aids (Hearing Aid) 12/2022 - 04/2022
1	Length of Stay 01/2023
1	Self-Help Devices (Assistive Technology) 12/2022
1	Long-Term Care 11/2022
1	Patient Readmission 01/2022
1	Percutaneous Coronary Intervention 01/2021